Search
Magnesium hydroxide
go.drugbank.com/drugs/DB09104ApprovedInvestigationalMagnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form. … Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite.
Mixtures: DUO Fusion, DUO FusionSynonyms: Hidroxido de magnesioBudesonide
go.drugbank.com/drugs/DB01222ApprovedInvestigational[A188529,A188532] Budesonide was granted FDA approval on 14 February 1994.[L10598] It is also available in a combination product with [formoterol].[L10619]
Mixtures: SYMBICORT TUR160UG/D 120ED, SYMBICORT TURBO160/4.5UG/DProducts: MIFLONIDE 200UG KAP+1INHAL, MIFLONIDE 200UG KAP+3INHALPropranolol
go.drugbank.com/drugs/DB00571ApprovedInvestigational[L6901,L6904,L6907] Propranolol was granted FDA approval on 13 November 1967.[L6904]
Products: PROPRA RATIO 10MG FTA, PROPRA RATIO 40MG FTAAllantoin
go.drugbank.com/drugs/DB11100ApprovedInvestigationalIn human muscle, urate is oxidized to allantoin during such exercise [FDA Label]. … Allantoin is a substance that is endogenous to the human body and also found as a normal component of human diets [FDA Label].
Mixtures: Dr Varogel, Dr Deep SkintonerProducts: D-Care, Dr. Oberon Natural BabyLosartan
go.drugbank.com/drugs/DB00678ApprovedInvestigational[L7423] Losartan was granted FDA approval on 14 April 1995.[L7423] … Losartan is an angiotensin II receptor blocker (ARB) used to treat hypertension.
Mixtures: LOSARTAN-KAL HCTAD100/25, LOSARTAN KAL HCTAD 100/25Products: DUP 753, Van-losartanCamphor
go.drugbank.com/drugs/DB01744ApprovedInvestigationalWithdrawnThe FDA ruled that camphorated oil could not be marketed in the United States and that no product could contain a concentration higher than 11%. … It is used topically as a skin antipruritic and as an anti-infective agent.
Mixtures: Au Kah Chuen Skin Lotion, Kaz InhalantSynonyms: D-Camphor, Camphor(D)Hydromorphone
go.drugbank.com/drugs/DB00327ApprovedIllicitInvestigationalDue to these modifications, it presents a very high potency and comparable side effect profile to the parent compound. … [A176495] The first reported approved product containing hydromorphone in the form of hydromorphone hydrochloride was developed by Fresenius Kabi USA and FDA approved in 1984.[L5795]
Products: PALLADONE RETARD 4MG KAP, PALLADONE RETARD 8MG KAPEtoposide
go.drugbank.com/drugs/DB00773ApprovedInvestigationalA semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair b...
Synonyms: 4-demethylepipodophyllotoxin β-D-ethylideneglucoside, 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-oneProducts: EPOSIN CONCENTRADO PARA SOLUCION DE INFUSION DE 20 MG/ML, SINTOPOZID 100 MG/5 ML IV KON. INFUZYON COZELTISI ICEREN FLAKON, 1 ADETKAI-1678
go.drugbank.com/drugs/DB16211InvestigationalKAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia).
KAI-1455
go.drugbank.com/drugs/DB06064ExperimentalIn preclinical studies, KAI-1455 showed a dramatic reduction in infarct size when delivered prior to the ischemic insult. … KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting